Literature DB >> 5067145

Risk of posttransfusion hepatitis in the United States. A prospective cooperative study.

G F Grady, A J Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5067145     DOI: 10.1001/jama.220.5.692

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  The economic impact of viral hepatitis in the United States.

Authors:  D D Tolsma; J A Bryan
Journal:  Public Health Rep       Date:  1976 Jul-Aug       Impact factor: 2.792

Review 2.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 3.  Pulmonary infections in immunocompromised children.

Authors:  V P Choudhry; S Choudhary
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

4.  [Prognosis in transfusion hepatitis].

Authors:  G Jakob
Journal:  Blut       Date:  1973-01

5.  An automated passive haemagglutination technique suitable for the detection of hepatitis B virus antigen and antibody in blood donors.

Authors:  M Nelson; E J Phipps; P G Watson; J R Watts; R Zwolenski
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

6.  Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.

Authors:  Ronald E Engle; Jens Bukh; Harvey J Alter; Suzanne U Emerson; Joni L Trenbeath; Hanh T Nguyen; Alicia Brockington; Tanaji Mitra; Robert H Purcell
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

7.  High-flow total body perfusion with severe hemodilution and normothermia in infants weighing less than 10 kg--safe limits of hemodilution in cardiopulmonary bypass in infants.

Authors:  M Kawamura; K Sakakibara; O Minamikawa; H Yokochi; A Kobayashi
Journal:  Jpn J Surg       Date:  1977-06

8.  Safe limit of hemodilution in cardiopulmonary bypass -comparative analysis between cyanotic and acyanotic congenital heart disease.

Authors:  M Kawamura; O Minamikawa; H Yokochi; S Maki; T Yasuda; Y Mizukawa
Journal:  Jpn J Surg       Date:  1980-09

Review 9.  Red cell transfusions and guidelines: a work in progress.

Authors:  Bruce D Spiess
Journal:  Hematol Oncol Clin North Am       Date:  2007-02       Impact factor: 3.722

10.  Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program.

Authors:  Evan M Bloch; Eteri Kipiani; Shaun Shadaker; Maia Alkhazashvili; Lia Gvinjilia; Tinatin Kuchuloria; Nazibrola Chitadze; Sheila M Keating; Amiran Gamkrelidze; Alexander Turdziladze; Vladimer Getia; Muazzam Nasrullah; Francisco Averhoff; Mariam Izoria; Beth Skaggs
Journal:  Transfusion       Date:  2020-05-04       Impact factor: 3.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.